近日，律师张女士称十年体检未有"患癌风险"预警，确诊已是肾癌晚期。对此，7月30日，爱康国宾举 办媒体说明会。 ...

Core Viewpoint - The controversy surrounding Aikang Guobin's health check services has intensified following allegations from lawyer Zhang Xiaoling regarding missed cancer diagnoses, leading to a formal lawsuit by the company against her for defamation [1][5][14] Group 1: Company Response - Aikang Guobin reiterated that there were no missed or erroneous diagnoses in Zhang's health checks and has filed a lawsuit for defamation based on her claims of "fabricating facts and spreading rumors" [1][5] - The company presented Zhang's 2023 health check report, which indicated potential issues but recommended further examinations, emphasizing the importance of regular follow-ups [3][4] - Aikang Guobin's CEO, Zhang Ligang, clarified that health checks are meant for risk assessment rather than definitive diagnoses, highlighting the limitations of low-cost health check packages [6][10] Group 2: Public and Media Reaction - Zhang Xiaoling has publicly welcomed the lawsuit and has called for Aikang Guobin to disclose her ten years of health check data, including ultrasound images and technician qualifications [4][5] - The company's statements regarding the nature of health checks have sparked significant public debate, with some media misrepresenting the CEO's comments, leading to accusations of defamation against the company [6][11][12] - Aikang Guobin reported a high volume of complaints on platforms like Black Cat Complaints, with 76.2% attributed to uncontrollable factors, while only 2.5% were related to medical service issues [14]

Core Viewpoint - The company, Aikang Group, has responded to allegations from a lawyer, Ms. Zhang, regarding a failure to detect kidney cancer during her ten years of health check-ups, asserting that there were no misdiagnoses or missed diagnoses in her medical evaluations [1][3][9] Group 1: Company Response - Aikang Group held a media briefing to address the claims made by Ms. Zhang, stating that an internal and external review confirmed the accuracy of her kidney examinations [1][3] - The company has filed a formal lawsuit against Ms. Zhang regarding her allegations, which has been accepted by the court [1][9] - Aikang Group provided detailed information about Ms. Zhang's health check data, equipment information, and quality control results to the relevant authorities [7] Group 2: Medical Evaluation Details - During her health check on October 9, 2023, at Aikang Group's Beijing West Branch, Ms. Zhang's ultrasound report indicated potential issues, including a left kidney hamartoma and a calcified lesion on the right kidney, with recommendations for further examination [3][8] - The company clarified that the cancer embryonic antigen (CEA) test, which Ms. Zhang referenced, is not relevant for early diagnosis of kidney cancer, as early detection primarily relies on imaging techniques [8]

Core Viewpoint - The company, Aikang Guobin, is taking legal action against a lawyer, Zhang, who claimed that her cancer was undetected during ten years of health check-ups, asserting that her allegations are false and damaging to the company's reputation [1][3]. Group 1: Company Response - Aikang Guobin has filed a lawsuit against Zhang for defamation, stating that her claims have harmed the dignity of its employees and misled the public about the private health examination industry [1][3]. - The company clarified that Zhang's health check-ups were part of a basic welfare package provided by the Beijing Lawyers Association, and she did not opt for any additional paid services except in 2017 [3]. - Aikang Guobin presented evidence from Zhang's recent health check-up, indicating the possibility of a renal tumor, and emphasized that the purpose of health examinations is to identify risk signals rather than provide definitive diagnoses [3][4]. Group 2: Industry Context - The company highlighted that over 4.8 million new cancer cases are diagnosed annually in China, with Aikang Guobin identifying approximately 15,000 cases, equating to one in every 320 diagnosed cancer patients [3]. - There have been multiple complaints against Aikang Guobin regarding inaccurate health reports and misdiagnoses, with a total of 1,220 complaints recorded on a consumer complaint platform [9]. - The company has undergone internal reviews and external expert evaluations, concluding that it bears no responsibility for Zhang's case and is open to third-party assessments [9].

"女律师体检10年未提示癌症"的体检门事件持续发酵。7月30日，身陷信任危机的爱康国宾官宣强势回 击动作。 在7月30日举行的媒体说明会上，爱康集团就"10年体检未预警肾癌"事件进行回应和澄清。会上爱康集 团高管郑重宣布：已就张女士虚构事实、散布谣言的侵权行为向法院提起正式诉讼，并获法院受理并立 案。 "张女士本应秉持职业操守，她却罔顾事实，通过造谣污蔑手段，通过网络媒体大肆发酵爱康国宾假体 检言论，开展了一场对爱康有组织的网暴。由于其行为严重损害爱康声誉，让每年约800万体检客户蒙 羞，更让民众对私营体检中心，乃至中国整个医疗行业产生不信任。在上述情况下，爱康认为，必须要 澄清事实，还原真相，爱康代表1.5万名爱康员工，向人民法院提请诉讼，现已正式立案受理。"公司高 管在会上表示。 对于爱康国宾今日的发布会，当事人张晓玲律师则告诉媒体，她已关注到，并录屏。 张晓玲表示，"我非常期待他们起诉我。目前还没看到对方发来的起诉状，没有接到任何通知。但已做 好100%的准备，随时应诉。" "体检不等于看病诊断" 发布会现场，爱康集团创始人、董事长兼CEO张黎刚提供了一组数字——中国每一年确诊的癌症患者大 约有480万 ...

Core Viewpoint - The company Aikang Guobin is facing public scrutiny and legal action following allegations from a client, Ms. Zhang, who claims that her cancer was not detected during ten years of health check-ups, leading to a lawsuit against her for defamation [2][6]. Group 1: Company Response - Aikang Guobin held a media briefing to address the allegations, stating that Ms. Zhang's health check on October 9, 2023, indicated a "possible renal hamartoma," which suggests a potential cancer diagnosis [2][3]. - The company emphasized that Ms. Zhang's health checks were part of a basic package provided by the Beijing Bar Association, and she had not purchased any additional services except in 2017 [3]. - Aikang Guobin's CEO, Zhang Ligang, commented on public misconceptions regarding the effectiveness of low-cost health checks, questioning the expectation that a basic check costing a few hundred yuan could detect all diseases [11]. Group 2: Public Reaction and Concerns - Public skepticism arose regarding the value of health checks if they fail to detect serious conditions, with many questioning the purpose of offering such services [3][11]. - Ms. Zhang publicly demanded transparency from Aikang Guobin, requesting the release of her past ultrasound results and the qualifications of the personnel involved in her checks [6][11]. - Complaints against Aikang Guobin have surged, with over a thousand reports on platforms like Black Cat Complaints, citing issues such as inaccurate results and misleading practices [14]. Group 3: Industry Context - The incident has highlighted broader concerns within the health check industry, with previous allegations of malpractice and the existence of "fake health checks" being raised by industry insiders [14]. - The CEO's past revelations about the industry's integrity have come back to haunt him, as the company now faces a "crisis of trust" among the public [14].

Core Viewpoint - Aikang Group held a media briefing to address the recent controversy regarding a patient, Ms. Zhang, who claimed that her kidney cancer was not detected during ten years of health check-ups. The company denied any malpractice and announced a formal lawsuit against Ms. Zhang for defamation [1][3]. Group 1: Company Response - Aikang Group refuted allegations of diagnostic errors in Ms. Zhang's kidney examinations and stated that her claims about the ultrasound report were fabricated [3]. - The company emphasized that early diagnosis of kidney cancer primarily relies on imaging techniques (CT/MRI) rather than blood tests, as per the NCCN guidelines [3]. - Aikang Group provided evidence of quality control for Ms. Zhang's cancer marker tests, asserting that all data is traceable and available for government verification [3][4]. Group 2: Medical Practices and Regulations - Aikang Group explained that the preservation period for blood samples is typically 1-7 days, making it impossible to provide ten years' worth of samples as requested by Ms. Zhang [4]. - The company confirmed that all medical personnel are certified and that all equipment and reagents comply with national regulations, ensuring strict adherence to quality control standards [4]. Group 3: Patient History and Diagnosis - Aikang Group outlined Ms. Zhang's medical history, indicating that her ultrasound in October 2023 suggested possible kidney tumors, and subsequent tests led to a diagnosis of early-stage kidney cancer in November 2024 [5]. - It was noted that Ms. Zhang was later diagnosed with metastatic kidney cancer in February 2025 after further examinations [5]. Group 4: Public Perception and Misunderstanding - Aikang Group's CEO highlighted the public's misconceptions regarding the capabilities of routine health check-ups, stating that a basic health check cannot replace comprehensive medical diagnostics [7]. - The CEO pointed out that the cost of routine check-ups is significantly lower than that of specialized medical consultations, which may lead to unrealistic expectations from patients [7].

凤凰网财经讯 7月30日上午，爱康集团举行媒体说明会，针对此前与张女士的癌症检查纠纷，爱康集团 资深副总裁周晓江宣布，已向法院提起诉讼，法院已正式立案受理。爱康集团董事长张黎刚表示，为了 维护爱康15000名员工的尊严，为了给行业正名，爱康不得不做出这个非常艰难的决定。 随后，爱康体检事件当事人@张晓玲律师再发微博喊话爱康国宾:"别遮遮掩掩的了，把我的10年超声检 查公布出来、给我检查的人员名单和资质公布出来、第三方是谁公布出来、结果公布出来，起诉内容公 布出来，我没也别整假患者、伪专家了!"她还表示，自己也没有收到爱康起诉的内容。 在上午举行的发布会上，爱康集团创始人、董事长兼CEO张黎刚表示，体检不等于看病诊断，其服务模 式不同于专科医生接诊，可以说是由体检套餐决定的，最主要的功能是帮助受检者发现疾病的蛛丝马 迹，后续找专科医生做进一步的诊断，而非替代临床诊断。因此，无论是在独立的体检中心还是在三甲 医院的体检中心，服务模式都是一样的。预防是最为经济有效的健康管理策略。健康体检作为预防医疗 的核心手段之一，一直以来都在发挥着积极的作用。 ...

7月30日，据东方财经等多家媒体消息，在上午的说明会上，爱康国宾表示，张女士造谣令员工深受伤害，已向法院提起诉讼，法院已正式立案受理。爱 康集团董事长张黎刚表示，为了维护爱康员工的尊严，为了给行业正名，爱康不得不做出这个非常艰难的决定。 会上，爱康国宾公开回应张女士体检报告，并表示根据现有公开信息，北大医院病例报告明确标注是早期肾癌，而不是张女士所述的晚期。 爱康国宾相关负责人李秀池在说明会称，张女士在爱康国宾的十年体检均为北京律师协会提供的福利基础套餐。除2017年外，张女士没有自费购买任何特 色或升级项目。 李秀池表示，张女士2023年10月9日在北京爱康国宾西内门诊部参加健康体检，体检结果显示有肾错构瘤可能。爱康国宾建议"首次发现者需要做CT，以 除外其他肾脏占位性病变"，李秀池称，"除外其他肾脏占位性病变"即是提示癌症可能性。 爱康国宾还公布了张女士2023年10月9日在北京爱康国宾西内门诊部参加体检的部分报告，其中专家建议与指导部分显示：肾钙化灶和肾错构瘤可能。 会上，爱康国宾还回应了"体检到底有没有用"这一问题。爱康国宾方表示：体检的核心是发现风险信号，而不是做出最终诊断。体检的意义是通过检查项 ...

每经编辑｜陈柯名 7月30日，据东方财经等多家媒体消息，在上午的说明会上，爱康国宾表示，张女士造谣令员工深受伤害，已向法院提起诉讼，法院已正式立案受理。爱 康集团董事长张黎刚表示，为了维护爱康员工的尊严，为了给行业正名，爱康不得不做出这个非常艰难的决定。 爱康国宾相关负责人表示，当事人张女士罔顾事实，通过网络臆想造谣、污蔑爱康国宾"假体检"，并恶意发酵。此举严重损害爱康国宾声誉，深深伤害了 二十余年来专注健康服务的数万名员工，更误导公众，引发对私营体检中心、乃至整个中国医疗行业的不当质疑。为澄清事实，还原真相，爱康国宾已依 法向法院提起诉讼，目前案件已获正式立案。 图片来源：红星新闻 会上，爱康国宾公开回应张女士体检报告，并表示根据现有公开信息，北大医院病例报告明确标注是早期肾癌，而不是张女士所述的晚期。 爱康国宾相关负责人李秀池在说明会称，张女士在爱康国宾的十年体检均为北京律师协会提供的福利基础套餐。除2017年外，张女士没有自费购买任何特 色或升级项目。 李秀池表示，张女士2023年10月9日在北京爱康国宾西内门诊部参加健康体检，体检结果显示有肾错构瘤可能。爱康国宾建议"首次发现者需要做CT，以 除外其他 ...